OTC Cold and Cough Medication Recalled Due to Crystallization
Denison Pharmaceuticals recalls Maximum Strength Cough and Chest Congestion and Nighttime Severe Cold and Flu Combo Pack due to crystallization and texture changes in affected bottles.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: FDA Class III recall for a quality defect (crystallization and lack of uniformity in product texture) rather than a direct health hazard. Class III recalls are the lowest classification and typically receive Low severity.
Plain-English summary
Denison Pharmaceuticals, LLC, through distributor Genexa Inc., is recalling Maximum Strength Cough and Chest Congestion and Nighttime Severe Cold and Flu Combo Pack. The recall involves 72,648 bottles distributed to two accounts that may have further distributed the product to retail locations. The product contains Dextromethorphan HBr, Guaifenesin, Acetaminophen, and Doxylamine Succinate (UPC 850015736155).
The recall was initiated due to crystallization and lack of uniformity in the product. Affected bottles contain chunky, grainy, and small crystal substances that represent a change in texture from the expected product consistency.
Affected lot numbers are 0104V (expiration 07/2025) and 0106V (expiration 09/2024). This is a Class III recall, the lowest classification for drug recalls.
The recalled product
- Product
- MAXIMUM STRENGTH COUGH AND CHEST CONGESTION AND NIGHTTIME SEVERE COLD AND FLU COMBO PACK (DEXTROMETHORPHAN HBR, GUAIFENESIN, ACETAMINOPHEN, DOXYLAMINE SUCCINATE)
- Brand
- MAXIMUM STRENGTH COUGH AND CHEST CONGESTION AND NIGHTTIME SEVERE COLD AND FLU COMBO PACK
- Manufacturer
- Denison Pharmaceuticals, LLC
- Affected units
- 72,648
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot# 0104V
- Exp 07/2025
- 0106V
- Exp 09/2024
UPCs (1)
- 850015736155
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 2 recalled by Denison Pharmaceuticals, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · MAXIMUM STRENGTH COUGH AND CHEST CONGESTION AND NIGHTTIME SEVERE COLD AND FLU COMBO PACK
- ModerateOTC cough and congestion medication recalled for crystallization
FDA (Drugs) · 2024-11-13
Same manufacturer · Denison Pharmaceuticals, LLC
See all →- HighAcne treatment gel recalled for benzene contamination nationwide
FDA (Drugs) · 2025-03-19
- HighLittle Remedies Gas Relief Drops Class II Recall for Manufacturing Deviations
FDA (Drugs) · 2024-06-26
- HighCough medicine recalled due to manufacturing process deviation with non-food lubricant
FDA (Drugs) · 2023-06-07
- HighCough Relief Medication Recalled for Non-Food Grade Lubricant Manufacturing Defect
FDA (Drugs) · 2023-06-07
- HighPin-Away Pyrantel Pamoate Recalled for Non-Food-Grade Lubricant Use in Manufacturing
FDA (Drugs) · 2023-06-07
Same hazard · crystallization
See all →- SeverePar Health Recalls Buprenorphine Hydrochloride Injection Due to Crystallization
FDA (Drugs) · 2026-10-07
- ModerateCyproheptadine Hydrochloride Syrup Recall Due to Precipitate
FDA (Drugs) · 2026-07-29
- HighBuprenorphine injection vials show crystallization identified as buprenorphine free base
FDA (Drugs) · 2026-06-24
- HighDapsone Topical Gel Recalled Due to Crystallization Defect
FDA (Drugs) · 2025-01-08
- ModerateDapsone Gel Recalled Nationwide for Crystallization
FDA (Drugs) · 2025-01-08
Similar recalls
- LowNovartis Recalls Comtrex Cold and Cough Caplets Due to Unknown Degradant
FDA (Drugs) · 2014-01-22
- LowNovartis Recalls Comtrex Nighttime Cold and Cough Due to Unknown Degradant
FDA (Drugs) · 2014-01-22
- HighCough Relief Medication Recalled for Non-Food Grade Lubricant Manufacturing Defect
FDA (Drugs) · 2023-06-07
- LowNovartis Recalls Maximum Strength Comtrex Due to Unknown Degradant
FDA (Drugs) · 2014-01-22
- HighChildren's Cough Medicine Recalled for Manufacturing Control Deficiency
FDA (Drugs) · 2022-09-14
- SevereOTC Cough and Cold Drug Recalled for Microbial Contamination
FDA (Drugs) · 2021-12-29